• One-step TUNEL Cy3 Apoptosis Detection Kit Guide

  2026-09-01

  Build a reproducible DNA fragmentation assay for cultured cells, frozen tissue, and paraffin sections with practical TdT-labeling controls. Learn how to pair Cy3 TUNEL imaging or flow cytometry with oncology workflows, including colorectal cancer treatment-response studies.

• Iptacopan Workflows for Complement Research

  2026-08-31

  Iptacopan (LNP023) enables selective alternative-pathway interrogation across serum, red-cell, and disease-model workflows. Its reversible factor B mechanism connects biochemical C3bBb inhibition with translational readouts such as C3 deposition, membrane attack complex formation, and hemolysis.

• Iptacopan (LNP023) Complement Research Workflows

  2026-08-31

  Build selective alternative-pathway experiments around Iptacopan, from factor B enzyme inhibition to serum MAC formation, C3 deposition, and complement-mediated hemolysis. The workflow emphasizes concentration-response design, pathway-specific controls, donor and species effects, and translation to complement-mediated disease models.

• Dabigatran in Thromboembolic Disorder Prevention

  2026-08-30

  The 2015 review by Enriquez and colleagues positioned Dabigatran as the first widely introduced non-vitamin K oral anticoagulant directed against thrombin, integrating its mechanism, pharmacokinetics, trial evidence, and safety considerations. Its findings support predictable fixed-dose anticoagulation across atrial fibrillation, venous thromboembolism, and orthopedic prophylaxis, while emphasizing renal clearance and bleeding management as important boundaries.

• Carrier-Platin and the ROS Storm in Cancer Cells

  2026-08-29

  Liu and colleagues developed carrier-platin, a polymer-confined platinum nanotherapeutic that rapidly generates intracellular reactive oxygen species and kills cancer cells independently of conventional DNA damage. The study suggests that catalytic redox activity, rather than platinum–DNA binding alone, can provide a distinct strategy for treating drug-resistant tumors while highlighting important questions about mechanism, delivery, and translational safety.

• GDC-0941 Workflows for PI3K/Akt Research

  2026-08-28

  Build reproducible PI3K/Akt pathway inhibition experiments with GDC-0941, from pAKT suppression and viability testing to resistance-model analysis. This practical guide connects pathway pharmacology with the DRD4–Akt–β-catenin mechanism implicated in liver cancer stem-cell phenotypes.

• Iptacopan (LNP023): Factor B Inhibition

  2026-08-28

  Iptacopan (LNP023) is an oral, selective complement factor B inhibitor that blocks alternative-pathway amplification. In a phase II PNH study, monotherapy rapidly reduced hemolysis and improved hemoglobin and transfusion outcomes. Its assay profile supports complement activation research from C3bBb inhibition to disease-model evaluation.

• Murine RNase Inhibitor for RNA Integrity

  2026-08-27

  Murine RNase Inhibitor provides targeted protection against pancreatic-type RNases in RT-PCR, cDNA synthesis, transcription, and RNA-labeling workflows. Its oxidation-resistant design is especially useful when reactions require low DTT, while its defined specificity helps researchers avoid masking unrelated nuclease activities.

• Gemini Quaternary Ammonium Compounds: 2024 Findings

  2026-08-27

  The reference study synthesized 16 novel gemini quaternary ammonium compounds and identified candidates with activity across bacteria, biofilms, fungi, and viruses. Its structure–activity analysis links polarity, membrane-related behavior, antimicrobial breadth, and cytotoxicity, offering a framework for evaluating alternatives to octenidine and benzalkonium chloride.

• Deferoxamine Mesylate in Ferroptosis Workflows

  2026-08-26

  Deferoxamine mesylate gives researchers a practical way to control labile iron while probing ferroptosis, oxidative stress, and HIF-1α stabilization. This guide connects iron chelation to resistant colorectal cancer assays, wound healing promotion, and tissue-protection workflows, with actionable setup and troubleshooting advice.

• Canagliflozin and mTOR: A Translational Map

  2026-08-26

  Canagliflozin hemihydrate is a focused SGLT2 probe for glucose metabolism research. New yeast-based evidence finds no TOR inhibition under the tested conditions, helping translational teams separate renal glucose reabsorption biology from mTOR pathway claims and design cleaner validation strategies.

• Streptavidin-FITC for LNP Trafficking Assays

  2026-08-25

  Streptavidin-FITC can do more than reveal biotinylated targets: it can help distinguish cargo retention from nanoparticle trafficking in LNP studies. This guide translates recent mechanistic findings into practical assay-design, labeling, imaging, and interpretation decisions.

• Streptozotocin Workflows for Diabetes Research

  2026-08-25

  Build more reproducible diabetes models with STZ by connecting β-cell injury, glucose confirmation, and neuropathy-focused readouts in one workflow. This guide distinguishes exploratory cell assays from animal induction studies and translates TBK1–microglia findings into practical experimental decisions.

• Mitomycin C Workflows for Cancer Research

  2026-08-24

  Mitomycin C is an antitumor antibiotic that gives cancer researchers a controllable way to study DNA replication inhibition, proliferation arrest, and apoptosis sensitization. This workflow-led guide covers stock preparation, dose finding, TRAIL combination experiments, immune-assay extensions, and troubleshooting for reproducible results.

• Type III Collagen Restricts Breast Cancer Progression

  2026-08-24

  The 2024 npj Breast Cancer study identifies type III collagen as a tumor-restrictive component of the breast cancer microenvironment rather than merely a structural matrix protein. By integrating fibroblast-derived matrices, patient tissue analysis, TCGA-BRCA bioinformatics, 3D culture, and mouse models, the authors show that increasing the type III-to-type I collagen balance may help restrain tumor growth and metastasis.

8672 records 7/579 page Previous Next First page 上5页 678910 下5页 Last page